News · 26 weeks43+70%
2026-03-012026-08-23
Mix3290d
- SEC Filings16(50%)
- Other11(34%)
- Earnings4(13%)
- Leadership1(3%)
Latest news
25 items- PRCuraleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value CreationAurora's selective statistics and misleading characterization of engagement do not obscure years of underperformance and lost shareholder valueCuraleaf reiterates its willingness to meet anytime to discuss a deal in the best interests of shareholdersSTAMFORD, Conn., Aug. 24, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.'s (TSX:ACB) (NASDAQ: ACB) ("Aurora") latest public statements regarding Curaleaf's offer for Aurora: "Aurora's hollow protests and completely misleading statistics ch
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAURORA CANNABIS CORRECTS INACCURATE STATEMENTS MADE IN SUPPORT OF CURALEAF HOLDINGS' HOSTILE BIDCuraleaf's self-serving portrayal of our business is an attempt to acquire Aurora's world class EU-GMP manufacturing facilities and global medical cannabis footprint at the lowest price possibleAurora's international strategy is working; net revenue is up 17%YOYContrary to Curaleaf's inaccurate statements, Aurora's high margin German business is growing and continues to be a key driver of Aurora's international growth strategyShareholders are advised to TAKE NO ACTION pending formal recommendation from the Board and Special Committee. Offer remains open for at least 105 days from the launch of the Hostile BidQuestions about the Offer or would like to stay informed? Please contact Kingsdale A
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis MarketEDMONTON, AB, Aug. 19, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that it has acquired Internode Pharma Limited, a licensed importer and wholesaler, and HAP Pharma Limited, a licensed pharmacy (the "Companies"). "The acquisition of Internode Pharma Limited and HAP Pharma Limited mark a further strategic milestone for Aurora as we continue to purposefully invest in expanding our leadership in the rapidly growing international medical cannabis market. We believe that this transaction will allow us
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.Curaleaf's decision to launch a hostile takeover bid is designed to pressure Aurora's shareholders into a short-term decision for the benefit of Curaleaf shareholders.Curaleaf's actions and comments reflect its objective: to acquire, at the lowest price possible, Aurora's market-leading EU-GMP facilities and global medical cannabis platform. Curaleaf's description of Aurora's business performance does not reflect our recently reported quarterly results and stated European medical cannabis strategy.Comments by Curaleaf's CEO failed to present the facts; Aurora has engaged with Curaleaf since June 2026, including as recently as August 12, 2026.Questions about the Offer or would like to stay in
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAURORA CANNABIS INC. RESPONDS TO PRESS RELEASE OF CURALEAF HOLDINGS, INC. REGARDING INTENTION TO LAUNCH UNSOLICITED TAKE-OVER BIDEDMONTON, AB, Aug. 11, 2026 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, responded today to a press release issued by Curaleaf Holdings, Inc. ("Curaleaf") regarding its stated intention to launch an unsolicited take-over bid for all of the issued and outstanding common shares of the Company (the "Aurora Shares") at a stated implied consideration of US$4.00 per Share, consisting of 0.3463 subordinate voting shares of Curaleaf plus US$0.75 in cash per Aurora Share (the "Proposal"). Aurora confirms that it received letters from Curaleaf
- PRCuraleaf Announces Intention to Launch Take-Over Bid for Aurora Cannabis to Solidify its Position as the Global Cannabis Industry LeaderProposed Offer reflects a 45% premium to Aurora's 30-day VWAP and a 110% premium to Aurora's 30-day VWAP excluding balance sheet cash Provides Aurora shareholders with the opportunity to become owners of the premier global cannabis platform and participate in the significant long-term upside of the combined companyCombines Aurora's EU-GMP cultivation and manufacturing capacity with Curaleaf's EU-GMP processing capabilities and international distribution platform to immediately enhance combined margins and accelerate patient access across Europe, Canada, Australia, and New Zealand Urges Aurora's Board to engage in good-faith discussions regarding the proposed transactionSTAMFORD, Conn., Aug.
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora, a Global Leader in Medical Cannabis, Announces Results of 2026 Annual General MeetingEDMONTON, AB, Aug. 10, 2026 /CNW/ -- Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting") held Friday August 7, 2026 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 16,639,306 common shares, representing 26.86% of Aurora's issued and outstanding common shares as of the record date. The details of the voting results for the directors are set out below: Board
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Cannabis Announces Fiscal 2027 First Quarter ResultsNASDAQ | TSX: ACBDelivers Net Revenue of $67.6 million, including a 17% YoY Increase in International Medical Cannabis Net RevenueSafari Flower Company Receives Three-Year EU-GMP Certification, Strengthens Ability to Supply Growing, High-Margin International Medical Cannabis MarketsMaintains Strong Balance Sheet with $149.1 million of Cash, Cash Equivalents2and Short-Term Investments with no DebtEDMONTON, AB, Aug. 5, 2026 /CNW/ -- Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter 2027 ending June 30, 2026.
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Receives Support from Leading Independent Proxy Adviser Institutional Shareholder Services Inc. for the 2026 Annual General Meeting of ShareholdersISS has recommended that Aurora's shareholders vote FOR all director nominees and meeting resolutionsShareholders are encouraged to vote early in favour of all resolutions – every vote matters, no matter how many shares you ownShareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and proxy solicitation agent, Kingsdale Advisors, by telephone at 1-800-749-9052 or by email at contactus@kingsdaleadvisors.com or visit www.MyAuroraVote.comEDMONTON, AB, July 27, 2026 /CNW/ -- Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, is pleased to announce that
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRSafari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara FacilityThe achievement strengthens Safari's ability to serve international medical cannabis markets under the strictest regulations EDMONTON, AB, July 23, 2026 /CNW/ -- Safari Flower Company ("Safari"), a wholly owned subsidiary of Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), is proud to announce the receipt of European Union Good Manufacturing Practice ("EU-GMP") certification for its Ontario facility, solidifying its ability to serve international medical cannabis markets. The certification is granted for a three-year term and validates Safari Flower Company's unwavering commitment to meeting the highest international standards for quality, compliance and operational excellence.
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Cannabis to Host First Quarter 2027 Investor Conference CallNASDAQ | TSX: ACBEDMONTON, AB, July 22, 2026 /CNW/ -- Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that will host an investor conference call on Wednesday, August 5, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time to discuss its financial results for the first quarter 2027. The Company will report its financial results prior to market open that same morning. Investor Conference Call DetailsDATE:Wednesday, August 5, 2026TIME:8:00 a.m. Eastern Time | 6:00 a.m. Mountain TimeWEBCAST:Click HereMiguel Martin, Executive Cha
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Named to TIME Canada's Best Companies 2026 ListNASDAQ | TSX: ACBThe Company makes history as the first and only cannabis company to ever receive this recognitionEDMONTON, AB, July 9, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, has been awarded on TIME Canada's Best Companies 2026 list. This win reflects the Company's differentiated performance and commitment to industry excellence. To view the full award list, visit TIME.com. This prestigious award is presented by TIME in collaboration with Statista, the world-leading statistics portal and industry ranking provider. Canada'
ACB FAQ
6 questionsWhat does Aurora Cannabis Inc. do?
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens...Where does ACB stock trade?
Aurora Cannabis Inc. (ACB) is listed on NYSE.What sector and industry is ACB in?
Aurora Cannabis Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about ACB?
Aurora Cannabis Inc. has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy on 2026-01-27. Recent price targets range from $960.00 to $1075.00.What companies are similar to ACB?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), DFTX (Definium Therapeutics Inc.), CGC (Canopy Growth Corporation). Compare ACB side-by-side with any of them on Quantisnow.How can I track ACB on Quantisnow?
Quantisnow aggregates Aurora Cannabis Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ACB to receive live email and push alerts on every new disclosure.